Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Memoru has inherited and continues clinical training programs in ketamine and psilocybin-assisted therapies, and is establishing clinics with a focus on clinical care, facilitator training, and research. Clinical results from NCPS era include successful cohort graduations and collaborations with MAPS for MDMA-therapy training but no registrational trials or commercial products yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Memoru Center for Visionary Healing Arts.